Statistics on Biotechnology Use  
Results by sector of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.079,519,179,381,
%Companies according to biotechnology used: Genetic code,35,46,29,23,
%Companies according to biotechnology used: Functional units,44,55,40,32,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,26,34,24,17,
%Companies according to biotechnology used: Bioprocesses,49,42,46,61,
%Companies according to biotechnology used: Sub-cellular organisms,8,12,6,5,
%Companies according to biotechnology used: Bio-computing,23,35,15,10,
%Companies according to biotechnology used: Nanobiotechnology,15,23,13,4,
%Companies according to biotechnology used: Other,12,12,18,10,
%Company by field(s) of ultimate application of biotechnology use: Human Health,48,68,43,22,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,21,25,15,17,
%Company by field(s) of ultimate application of biotechnology use: Food products,33,25,30,46,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,22,22,21,22,
%Company by field(s) of ultimate application of biotechnology use: Environment,17,15,25,17,
%Company by field(s) of ultimate application of biotechnology use: Industry,15,16,20,10,
Personnel in R&D in biotechnology (no. of persons),9.795,5.614,1.560,2.621,
Personnel in R&D in biotechnology (no. of persons): Researchers,5.573,3.578,874,1.122,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.222,2.036,686,1.500,
Personnel in R&D in biotechnology (no. of persons): women,5.298,3.242,813,1.243,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.925,1.944,462,520,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.373,1.298,352,724,
Personnel in R&D in biotechnology (FTE),6.828,6,4.507,9,873,3,1.447,5,
Personnel in R&D in biotechnology (FTE): Researchers,4.106,5,2.926,2,542,5,637,8,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.722,1,1.581,7,330,8,809,6,
Personnel in R&D in biotechnology (FTE): women,3.811,7,2.613,9,467,5,730,3,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.190,7,1.587,2,290,9,312,7,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.621,1.026,8,176,7,417,6,
Internal expenditure on R&D (thousands of euros),533.826,364.396,71.517,97.913,
1) By nature of the expense: Current expenses,492.955,336.315,63.751,92.889,
1.1) Remuneration to researchers,203.439,146.489,27.774,29.176,
1.2) Remuneration to technicians and assistants,96.850,59.163,11.408,26.279,
1.3) Other current expenses,192.666,130.663,24.568,37.434,
2) By nature of the expense: Capital expenses,40.870,28.081,7.766,5.024,
2.1) Land and buildings,7.521,3.628,3.306,587,
2.2) Equipment and instruments,32.078,23.504,4.431,4.144,
2.3) Acquisition of specific R+D software,1.270,949,28,293,
1) By origin of the funds: National funds,432.869,285.656,66.748,80.466,
1.1) Own funds,319.046,209.128,49.733,60.186,
1.2) From companies,39.253,26.512,5.269,7.473,
1.3) Public Administration funds,70.063,47.559,11.542,10.962,
1.4) From Universities,156,131,10,14,
1.5) From non profit private institutions,4.351,2.326,194,1.831,
1) By origin of the funds: Foreign funds,100.956,78.740,4.769,17.447,
2.1) From EU programmes,20.070,15.152,3.718,1.200,
2.2) Other foreign funds,80.886,63.588,1.051,16.247,
Purchase of R&D services in biotechnology (thousands of euros),138.625,109.756,20.480,8.390,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,101.114,75.199,17.964,7.950,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,37.512,34.557,2.515,440,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,46,57,43,33,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,12,15,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,12,14,15,8,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,14,14,19,12,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,19,21,23,14,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,19,23,22,13,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,18,19,16,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,41,42,30,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,49,53,57,41,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,21,20,16,
% Companies that have requested biotechnology patents,15,23,13,6,
Number of patents requested,466,349,74,42,
% Companies with income of an international origin related to biotechnological activities,24,9,33,14,5,18,8,
% Turnover representing income of an international origin related to biotechnological activities,0,9,11,2,0,0,3,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,71,3,76,7,54,2,32,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,28,7,23,3,45,8,68,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,92,2,92,9,56,5,92,4,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,2,4,2,2,23,8,0,6,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,3,0,9,19,7,0,7,
% Income of an international origin related with activities according to the classification: Other,4,2,4,.,6,3,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute